fluconazole has been researched along with Hand Dermatosis in 30 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Systemic treatment of onychomycosis is based these last years on the new drug utilization aiming to decrease the length of the treatment and secondary effects particularly with fluconazole." | 9.12 | [Fluconazole and treatment of onychomycosis. About 86 cases]. ( Ben Osman Dhahril, A; Bouassida, S; Denguezli, M; Doss, N; El Euch, D; Ezzine, N; Kourda, M; Mokhtar, I; Nouira, R; Ridha Kamoun, M; Turki, H, 2006) |
| "The purpose of this study was to assess the safety and efficacy of oral fluconazole 150, 300, and 450 mg administered once weekly compared with placebo in the treatment of distal subungual onychomycosis of the fingernail caused by dermatophytes." | 9.08 | Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail. ( Babel, D; Breneman, D; Bucko, AD; Drake, L; Elewski, BE; Ellis, CN; Greer, DL; Hanifin, JM; Kang, S; Katz, HI; Leyden, JJ; Ling, MR; Martin, AG; McDonald, CJ; Morman, MR; Muglia, J; Pariser, DM; Pariser, RJ; Rich, P; Savin, RC; Scher, RK; Shupack, JL; Stewart, DM; Tschen, EH; Webster, G, 1998) |
| "Determinations of plasma and fingernail concentrations of fluconazole were performed as part of a larger study comparing the safety and efficacy of once-weekly fluconazole (150, 300, and 450 mg) to placebo in the treatment of distal subungual onychomycosis of the fingernails caused by dermatophytes." | 9.08 | Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail. ( Babel, D; Breneman, D; Bucko, AD; Drake, L; Elewski, BE; Ellis, CN; Friedman, D; Hanifin, JM; Hilbert, J; Kang, S; Katz, HI; Leyden, JJ; Ling, MR; Martin, AG; McDonald, CJ; Morman, MR; Muglia, J; Pariser, DM; Pariser, RJ; Rich, P; Savin, RC; Scher, RK; Stewart, DM; Tschen, EH; Webster, G, 1998) |
| "Our purpose was to evaluate the intermittent use of fluconazole (either once-weekly or alternate-day dosing) without concurrent nail avulsion in patients with moderate to severe onychomycosis." | 7.69 | Intermittent fluconazole dosing in patients with onychomycosis: results of a pilot study. ( Assaf, RR; Elewski, BE, 1996) |
| "We report a case of fingernail onychomycosis in an immunosuppressed renal transplant patient who was successfully treated with once-weekly fluconazole therapy." | 7.68 | Onychomycosis: successful treatment with once-weekly fluconazole. ( Nahass, GT; Sisto, M, 1993) |
| "We report three cases of sporotrichosis successfully treated with oral fluconazole." | 7.68 | Successful treatment of sporotrichosis with oral fluconazole: a report of three cases. ( Belda Júnior, W; Castro, LG; Cucé, LC; Sampaio, SA; Stevens, DA, 1993) |
| "Systemic treatment of onychomycosis is based these last years on the new drug utilization aiming to decrease the length of the treatment and secondary effects particularly with fluconazole." | 5.12 | [Fluconazole and treatment of onychomycosis. About 86 cases]. ( Ben Osman Dhahril, A; Bouassida, S; Denguezli, M; Doss, N; El Euch, D; Ezzine, N; Kourda, M; Mokhtar, I; Nouira, R; Ridha Kamoun, M; Turki, H, 2006) |
| "The purpose of this study was to assess the safety and efficacy of oral fluconazole 150, 300, and 450 mg administered once weekly compared with placebo in the treatment of distal subungual onychomycosis of the fingernail caused by dermatophytes." | 5.08 | Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail. ( Babel, D; Breneman, D; Bucko, AD; Drake, L; Elewski, BE; Ellis, CN; Greer, DL; Hanifin, JM; Kang, S; Katz, HI; Leyden, JJ; Ling, MR; Martin, AG; McDonald, CJ; Morman, MR; Muglia, J; Pariser, DM; Pariser, RJ; Rich, P; Savin, RC; Scher, RK; Shupack, JL; Stewart, DM; Tschen, EH; Webster, G, 1998) |
| "Determinations of plasma and fingernail concentrations of fluconazole were performed as part of a larger study comparing the safety and efficacy of once-weekly fluconazole (150, 300, and 450 mg) to placebo in the treatment of distal subungual onychomycosis of the fingernails caused by dermatophytes." | 5.08 | Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail. ( Babel, D; Breneman, D; Bucko, AD; Drake, L; Elewski, BE; Ellis, CN; Friedman, D; Hanifin, JM; Hilbert, J; Kang, S; Katz, HI; Leyden, JJ; Ling, MR; Martin, AG; McDonald, CJ; Morman, MR; Muglia, J; Pariser, DM; Pariser, RJ; Rich, P; Savin, RC; Scher, RK; Stewart, DM; Tschen, EH; Webster, G, 1998) |
| "Our purpose was to evaluate the intermittent use of fluconazole (either once-weekly or alternate-day dosing) without concurrent nail avulsion in patients with moderate to severe onychomycosis." | 3.69 | Intermittent fluconazole dosing in patients with onychomycosis: results of a pilot study. ( Assaf, RR; Elewski, BE, 1996) |
| "We report a case of fingernail onychomycosis in an immunosuppressed renal transplant patient who was successfully treated with once-weekly fluconazole therapy." | 3.68 | Onychomycosis: successful treatment with once-weekly fluconazole. ( Nahass, GT; Sisto, M, 1993) |
| "We report three cases of sporotrichosis successfully treated with oral fluconazole." | 3.68 | Successful treatment of sporotrichosis with oral fluconazole: a report of three cases. ( Belda Júnior, W; Castro, LG; Cucé, LC; Sampaio, SA; Stevens, DA, 1993) |
| "Onychomycosis is a public health concern because of its high world wide prevalence, and its potential for spread of fungal elements to others." | 2.41 | [How to improve efficacy of onychomycosis treatment?]. ( Nowicki, R, 2001) |
| " In addition, the short treatment times (< 3 months) and intermittent dosing schedules are likely to enhance compliance and reduce the costs of therapy." | 2.40 | Onychomycosis: pathogenesis, diagnosis, and management. ( Elewski, BE, 1998) |
| "Cutaneous cryptococcosis is a systemic fungal disease; it is commonly observed in immunocompromised patients." | 2.39 | [Cryptococcal whitlow in a HIV positive patient]. ( Cren, P; Dompmartin, A; Duhamel, C; Galateau, F; Le Maitre, M; Leroy, D; Moreau, A; Six, M; Verneuil, L, 1995) |
| "The management of onychomycosis has changed considerably in the past few years." | 2.38 | Onychomycosis. Agents of choice. ( Hay, RJ, 1993) |
| "Fluconazole (Fungolon) has only been recently used in the treatment of nail fungal infections." | 1.32 | Fluconazole (Fungolon) in the treatment of onychomycoses. ( Zisova, LG, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (46.67) | 18.2507 |
| 2000's | 10 (33.33) | 29.6817 |
| 2010's | 5 (16.67) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, M | 1 |
| Paul, N | 1 |
| Fernandez, C | 1 |
| Wakelin, S | 1 |
| Mosojane, KI | 1 |
| Sowash, M | 1 |
| Williams, VL | 1 |
| Kovarik, CL | 1 |
| Seidl, HP | 1 |
| Jäckel, A | 1 |
| Müller, J | 1 |
| Schaller, M | 1 |
| Borelli, C | 1 |
| Polak, A | 1 |
| Oza, V | 1 |
| Asch, S | 1 |
| Mathes, EF | 1 |
| Vázquez-Osorio, I | 1 |
| García-Rodiño, S | 1 |
| Rodríguez-Rodríguez, M | 1 |
| Labandeira, J | 1 |
| Suárez-Peñaranda, JM | 1 |
| Sánchez-Aguilar, M | 1 |
| Vázquez-Veiga, H | 1 |
| Gyimesi, A | 1 |
| Bátor, A | 1 |
| Görög, P | 1 |
| Telegdy, E | 1 |
| Szepes, É | 1 |
| Kappéter, Á | 1 |
| Gyulai, R | 1 |
| Lengyel, Z | 1 |
| Rao, R | 1 |
| Shenoi, SD | 1 |
| Zisova, LG | 1 |
| Negroni, R | 1 |
| Tuculet, MA | 1 |
| El-Komy, MH | 1 |
| Hiruma, M | 1 |
| Nowicki, R | 1 |
| El Euch, D | 1 |
| Bouassida, S | 1 |
| Kourda, M | 1 |
| Ezzine, N | 1 |
| Denguezli, M | 1 |
| Mokhtar, I | 1 |
| Doss, N | 1 |
| Turki, H | 1 |
| Ridha Kamoun, M | 1 |
| Nouira, R | 1 |
| Ben Osman Dhahril, A | 1 |
| Figueiredo, VT | 1 |
| de Assis Santos, D | 1 |
| Resende, MA | 1 |
| Hamdan, JS | 1 |
| Allegue, F | 1 |
| de Lis, MP | 1 |
| Pérez-Alvarez, R | 1 |
| Yu, RY | 1 |
| Gao, L | 1 |
| Hay, RJ | 1 |
| Nahass, GT | 1 |
| Sisto, M | 1 |
| Castro, LG | 1 |
| Belda Júnior, W | 1 |
| Cucé, LC | 1 |
| Sampaio, SA | 1 |
| Stevens, DA | 1 |
| Verneuil, L | 1 |
| Dompmartin, A | 1 |
| Duhamel, C | 1 |
| Cren, P | 1 |
| Six, M | 1 |
| Le Maitre, M | 1 |
| Galateau, F | 1 |
| Moreau, A | 1 |
| Leroy, D | 1 |
| Assaf, RR | 1 |
| Elewski, BE | 5 |
| Montero-Gei, F | 1 |
| Robles-Soto, ME | 1 |
| Schlager, H | 1 |
| Kusuhara, M | 1 |
| Hachisuka, H | 1 |
| Drake, L | 2 |
| Babel, D | 2 |
| Stewart, DM | 2 |
| Rich, P | 2 |
| Ling, MR | 2 |
| Breneman, D | 2 |
| Scher, RK | 3 |
| Martin, AG | 2 |
| Pariser, DM | 2 |
| Pariser, RJ | 2 |
| Ellis, CN | 2 |
| Kang, S | 2 |
| Katz, HI | 2 |
| McDonald, CJ | 2 |
| Muglia, J | 2 |
| Savin, RC | 2 |
| Webster, G | 2 |
| Leyden, JJ | 2 |
| Bucko, AD | 2 |
| Tschen, EH | 2 |
| Hanifin, JM | 2 |
| Morman, MR | 2 |
| Shupack, JL | 1 |
| Greer, DL | 1 |
| Friedman, D | 1 |
| Hilbert, J | 1 |
| Tietz, HJ | 1 |
| Czaika, V | 1 |
| Sterry, W | 1 |
| Tseng, SS | 1 |
| Longley, BJ | 1 |
| Treiber, RK | 1 |
| Baran, R | 1 |
8 reviews available for fluconazole and Hand Dermatosis
| Article | Year |
|---|---|
Acrokeratosis paraneoplastica (Bazex syndrome): an atypical presentation.
Topics: Adenocarcinoma; Antifungal Agents; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Hyperpigme | 2004 |
[Onychomycosis: recent progress in the epidemiology, diagnosis and treatment].
Topics: Administration, Topical; Antifungal Agents; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; I | 2006 |
[How to improve efficacy of onychomycosis treatment?].
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifungal Agents; Dermatomycoses; Drug Therapy, C | 2001 |
Onychomycosis. Agents of choice.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Candidiasis, Cutaneous; Fluconaz | 1993 |
[Cryptococcal whitlow in a HIV positive patient].
Topics: Aged; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Fingers; Fluconazole; Hand Dermatoses | 1995 |
Lymphocutaneous infection due to Scedosporium apiospermum.
Topics: Aged; Antifungal Agents; Biopsy, Needle; Dermatomycoses; Diagnosis, Differential; Fluconazole; Follo | 1997 |
Once-weekly fluconazole in the treatment of onychomycosis: introduction.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Foot Dermatoses; Han | 1998 |
Onychomycosis: pathogenesis, diagnosis, and management.
Topics: Adult; Antifungal Agents; Child; Diagnosis, Differential; Female; Fluconazole; Foot Dermatoses; Hand | 1998 |
5 trials available for fluconazole and Hand Dermatosis
| Article | Year |
|---|---|
Nailfold fluconazole fluid injection for fingernail onychomycosis.
Topics: Antifungal Agents; Fluconazole; Hand Dermatoses; Humans; Injections; Onychomycosis | 2006 |
[Fluconazole and treatment of onychomycosis. About 86 cases].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Fluconazole; Follow-Up Studies; Foot Dermatoses; | 2006 |
Fluconazole in the treatment of severe onychomycosis.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antifungal Agents; Arthrodermataceae; Female; Fluconazole; | 1996 |
Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Arthrodermataceae; Dose-Response Relationship, Drug; Dou | 1998 |
Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Female; Fluconazole; Hand Dermatoses; | 1998 |
17 other studies available for fluconazole and Hand Dermatosis
| Article | Year |
|---|---|
Fluconazole-induced fixed drug eruption confirmed by extemporaneous patch testing.
Topics: Antifungal Agents; Candidiasis, Oral; Drug Eruptions; Female; Fluconazole; Hand Dermatoses; Humans; | 2020 |
Multifocal verrucous plaques in an apparently immunocompetent female.
Topics: Adult; Amphotericin B; Antifungal Agents; Dermatomycoses; Female; Fluconazole; Hand Dermatoses; Huma | 2018 |
Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections.
Topics: Antifungal Agents; Candida albicans; Ciclopirox; Epidermophyton; Fluconazole; Hand Dermatoses; Human | 2015 |
Three-Day-Old Boy With Palmar Pustules.
Topics: Antifungal Agents; Candidiasis, Cutaneous; Diagnosis, Differential; Fluconazole; Gestational Age; Ha | 2016 |
Criptococosis cutánea primaria en paciente inmunocompetente.
Topics: Aged; Antifungal Agents; Cryptococcosis; Dermatomycoses; Fluconazole; Hand Dermatoses; Humans; Immun | 2016 |
Cutaneous Cryptococcus albidus infection.
Topics: Aged, 80 and over; Antifungal Agents; Cryptococcosis; Cryptococcus; Dermatomycoses; Facial Dermatose | 2017 |
Fluconazole (Fungolon) in the treatment of onychomycoses.
Topics: Adult; Aged; Antifungal Agents; Female; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Male; | 2004 |
[Clinical cases in medical mycology. Case No. 16].
Topics: Adolescent; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Blood Sedimen | 2005 |
Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Ciclopirox; Fluconazole; Hand Dermatoses; Humans; I | 2007 |
Primary cutaneous cryptococcosis presenting as a whitlow.
Topics: Aged; Antifungal Agents; Cryptococcosis; Dermatomycoses; Fluconazole; Hand Dermatoses; Hemorrhage; H | 2007 |
Chromoblastomycosis successfully treated with fluconazole.
Topics: Chromoblastomycosis; Cladosporium; Fluconazole; Hand Dermatoses; Humans; Injections, Intravenous; Le | 1994 |
Onychomycosis: successful treatment with once-weekly fluconazole.
Topics: Drug Administration Schedule; Female; Fluconazole; Follow-Up Studies; Hand Dermatoses; Humans; Immun | 1993 |
Successful treatment of sporotrichosis with oral fluconazole: a report of three cases.
Topics: Administration, Oral; Adult; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Age | 1993 |
Intermittent fluconazole dosing in patients with onychomycosis: results of a pilot study.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifun | 1996 |
Case report. Osteomyelitis caused by high resistant Candida guilliermondii.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fingers; Fluconazole; Hand Derm | 1999 |
Fusarium fingernail infection responsive to fluconazole intermittent therapy.
Topics: Adult; Antifungal Agents; Drug Administration Schedule; Female; Fluconazole; Fusarium; Hand Dermatos | 2000 |
[New treatments of onychomycoses].
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Fluconazole; Foot Dermatoses; H | 1992 |